In conclusion, our results demonstrate that AE-BCT exerts anti-metastatic effects on highly malignant cancer cells by suppressing MMP-9 activity through inhibition of ROS-mediated NF-κB activation (Fig. 8). Here, MMP9 is linked to cancer.